Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
clinical trials
colucid pharmaceuticals
2
×
eli lilly
fda
indiana blog main
indiana top stories
lasmiditan
life sciences
national blog main
raleigh-durham blog main
raleigh-durham top stories
aimmune therapeutics
alopecia areata
alprazolam
amarin
amgen
arena pharmaceuticals
avapritinib
blueprint medicines
boehringer ingelheim
boston top stories
boulder/denver blog main
boulder/denver top stories
cadent therapeutics
cancer
cancer immunotherapy
celgene
centers for disease control and prevention
centrexion therapeutics
cgrp inhibitors
chronic migraine
concert pharmaceuticals
detroit blog main
detroit top stories
dragonfly therapeutics
drug enforcement administration
esophageal cancer
galcanezumab
What
acute
addresses
approval
arena’s
bio
bounty
causes
cig
comeback
companies
condition
corner
deals
decades
delivered
drug
eli
expressing
fda
friday
giant
giving
ipo
lasmiditan
life
lilly
lilly’s
little
medication
migraine
moderna’s
new
number
oks
pharmaceutical
roundup
science
second
survey
thanks
Language
unset
Current search:
" colucid pharmaceuticals "
×
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More
